In the title compound, C 25 H 36 O 6 , the two central cyclohexane rings exhibit a chair conformation. The terminal cyclohexene and cyclopentane rings are in half-chair and envelope conformations (with the C atom bearing the methyl substituent as the flap), respectively. The methyl group of the butyrate chain is disordered over two orientations, with a refined occupancy ratio of 0.742 (6):0.258 (6). Intramolecular O-HÁ Á ÁO and C-HÁ Á ÁO hydrogen bonds are observed. In the crystal, molecules are linked by O-HÁ Á ÁO hydrogen bonds into chains running parallel to the a axis.
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S1. Comment
Hydrocortisone 17-butyrate is an important cortical hormone drug derived from the esterification reaction of hydrocortisone at the hydroxyl group of C-17. Due to the introduction of the alkyl chain, hydrocortisone 17-butyrate showed increased lipophicity and affinity for receptors, which lead to increased pharmacological activity (Haapasaari et al., 1995; Lerche et al., 2010; D′Erme & Gola, 2012) . Compared with hydrocortisone, it showed increased anti-inflammatory activity, immunosuppressive properties, and low side effect. Due to the outstanding characteristics of hydrocortisone 17-butyrate, it has drawn great attention of the experts from the fields of chemistry, pharmacy and medicine. The synthesis and properties have been investigated quite extensively, while its molecular structure has not been reported. Here we present the single-crystal X-ray diffraction study of hydrocortisone 17-butyrate.
The molecular structure of the title compound is shown in Figure 1 . As expected, the chiral carbon atoms C8, C9, C11, C13, and C14 exhibit S configuration, and atoms C10 and C17 exhibit R configuration. The Flack parameter is 0.02 (18). (Table 1 ). In the crystal, molecules are connected by intermolecular O-H···O hydrogen bonds to form chains parallel to the a axis.
S2. Experimental
The title compound was obtained following a patent report (Sun et al., 2009) . At 0-5°C, butyryl chloride (1.5 mmol, 0.16 mL) was added dropwise to a CH 2 Cl 2 (10 mL) solution containing hydrocortisone 21-acetate (1 mmol, 0.4 g), Et 3 N (4 mL) and 4-dimethylaminopyridine (0.05 mmol, 6 mg). The mixture was then stirred at 0°C for 3 hours before being treated with HCl to reach a pH of 2. The mixture was then washed with H 2 O to reach neutrality, and extracted using 
S3. Refinement
The C25 methyl carbon atom is disordered over two orientations with refined occupancy ratio 0.742 (6):0.258 (6). The disordered atoms were refined by constraining the C24-C25 and C24-C25A bond lengths to be 1.52 (1) Å and by restraining the anisotropic displacement ellipsoids to be equal. The hydroxyl H atom bound to O4 was located in a difference Fourier map and refined freely. All other H atoms were placed in calculated positions and refined as riding, with C-H = 0.93-0.97 Å, O-H = 0.82 Å, and with U iso (H) = 1.2U eq (C) or 1.5U eq (C) for methyl and hydroxyl H atoms.
A rotating model was applied to the methyl and hydroxyl groups. One outlier (0 1 1) was omitted in the last cycles of refinement.
Figure 1
The molecular structure of the title compound showing 30% probability displacement ellipsoids. 
